Cargando…
(68)Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy
Biochemical recurrence (BCR) of prostate cancer (PCa) occurs in about 25% of patients treated with radical prostatectomy (RP) and up to 45% in patients who receive external beam radiotherapy (RT). Early diagnosis of PCa recurrence is of high importance for successful salvage therapy. The aim of the...
Autores principales: | Haidar, Mohamad, Abi-Ghanem, Alain S., Moukaddam, Hicham, Jebai, Malak El, Al Zakleet, Safaa, Al Rayess, Samir, Akkawi, Abdul Rahman, Kassas, Mutaz, Tamim, Hani, Hajj, Albert El, Estrada-Lobato, Enrique, Osman, Medhat M., Shamseddine, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705359/ https://www.ncbi.nlm.nih.gov/pubmed/36443430 http://dx.doi.org/10.1038/s41598-022-24688-3 |
Ejemplares similares
-
The Clinical Significance of Incidental GIT Uptake on PET/CT: Radiologic, Endoscopic, and Pathologic Correlation
por: Hosni, Mohammad N., et al.
Publicado: (2023) -
Prone versus Supine FDG PET/CT in the Staging of Breast Cancer
por: Nassar, Lara, et al.
Publicado: (2023) -
Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer
por: Barakat, Andrew, et al.
Publicado: (2020) -
(44)Sc-PSMA-617 for radiotheragnostics in tandem with (177)Lu-PSMA-617—preclinical investigations in comparison with (68)Ga-PSMA-11 and (68)Ga-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2017) -
In vitro and in vivo comparative study of a novel (68)Ga-labeled PSMA-targeted inhibitor and (68)Ga-PSMA-11
por: Chen, Huanyu, et al.
Publicado: (2021)